ARYA Sciences Acquisition V priced its IPO of 13 million Class A ordinary shares at $10 each.
Shares begin trading today on the Nasdaq under ARYE.
ARYA V intends to focus on the healthcare industry in the United States and other developed countries. The company expects to focus on target businesses with valuations of $300 million to $500 million or more and that have the potential for $1 billion or more market capitalization.
Jefferies and Goldman Sachs are joint book-running managers for the offering. The underwriters have a 45-day option to purchase up to an additional 1.95 shares to cover over-allotments, if any.
The offering is expected to close July 15. Read more.
